← Open Payments lookup

STEPHANIE SANDERS DENIUS: Open Payments

NPI 1881667327 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,282 in 55 payments from 16 companies in 2025. Trend: 2023 $727 · 2024 $730 · 2025 $1,282

Food & beverage: $1,282
CompanyPaymentsAmount
Novo Nordisk Inc14$408
Lilly USA, LLC11$183
ABBVIE INC.8$167
Madrigal Pharmaceuticals1$108
Exact Sciences Corporation3$66
AstraZeneca Pharmaceuticals LP3$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$52
Boehringer Ingelheim Pharmaceuticals, Inc.2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
PFIZER INC.2$34

Products named: Ozempic, Rybelsus, MOUNJARO, REZDIFFRA, Wegovy, VRAYLAR, JARDIANCE, XIFAXAN.

Industry payments across MD — which companies pay providers there.